NewsRoom Articles - Page 246 of 252

TuesdayJul 21, 2020 10:00 am

5 Mistakes to Avoid When Budgeting for a Clinical Trial

Making a concrete budget for clinical trials is always challenging yet sponsors of these clinical trials always try their best to plan adequately for every dollar they will need. However, there are still some unforeseen costs that always emerge. It is therefore always better to budget for the unseen rather than being surprised later. Most of the established clinical research organizations have carried out many clinical pieces of research hence have the expected experience. Here are some of the mistakes that can be avoided when budgeting for a clinical trial. Avoid Clinical Trial Delays A lot of clinical trials always…

MondayJul 20, 2020 3:00 pm

7 Signs You Need the Services of a Contract Research Organization

Clinical trials may sometimes be so cumbersome, especially when you are working on it alone. Successful clinical trials require the help of a good Contract Research Organization (“CRO”). The right CRO will add great value to your research, especially while dealing with critical elements. What is a Contract Research Organization? It is a company that supports clinical research by providing outsourced services such as auditing, training, monitoring, data and project management. A well-established CRO will offer all the services mentioned above or even more. A CRO team can provide its support throughout the clinical trial or may come in at…

MondayJul 20, 2020 10:00 am

Could Daily Aspirin Intake Prevent Colorectal Cancer?

The most common cause of hereditary colorectal (colon) cancer is Lynch Syndrome (“LS”). People with Lynch Syndrome have a 70% higher risk of developing colorectal cancer in their lifetime than the general population, and colorectal cancer is the leading cause of death among cancer cases in the U.S. Additionally, people with LS often develop colorectal cancer at much younger ages compared to the healthy population. However, there are no specific drugs that cure cancer, but following the set guidelines by the National Institute for Health and Care (“NICE”) in the UK, there may be some significant news. The information discussed…

FridayJul 17, 2020 2:30 pm

Using Protein Biomarkers Enhances Clinical Trial Outcomes

It is crystal clear that clinical trials are the surest way to bring new drugs into the market. While most clinical trials are costly, nine out of ten drugs in clinical development are never approved. Most of these treatments fail in clinical trials due to a lack of the desired effect, and some of these failures are attributed to poor target selection during the drug discovery process. Matching the right treatment to the right patient based on molecular biomarkers can bring more promising results in clinical trials. Precision Medicine Requires Reliable Biomarkers Precision medicine aims to treat patients as individuals.…

FridayJul 17, 2020 10:00 am

How Clinical Researchers Can Stay Productive During This Crisis

The normal day to day operations of all sectors have been affected by the outbreak of COVID-19, and it has made most non-essential employees resort to working from home. The medical industries have not been spared, and this has stalled a lot of clinical research. Clinical visits and schedules have also been cancelled due to this pandemic. However, clinical researchers can remain productive during this crisis through the following ways: Engage in Training and Re-training If it has been long since you reviewed the Code of Federal Regulations, this is the best opportunity to undertake some in-depth training. Your team…

ThursdayJul 16, 2020 3:00 pm

An Exploration of Gene and Cell Therapy

Cell and gene therapies are at the frontline of advancement in personalized medicine, and they are also two overlapping fields in medical research. Gene and cell therapy aim to treat the underlying causes of both acquired and genetic disease. Cell therapy It is a process in which intact live cells are given to a patient through injection, graft, or implantation to relieve or eradicate a disease. It is always done by using cells to carry therapy through the body. Besides, it can also be achieved by restoring a set of cells impacted by a disease. Today, most cell therapies are…

ThursdayJul 16, 2020 12:56 pm

DarioHealth Corp. (NASDAQ: DRIO) Named Global Player in Digital Diabetes Management Market

The company was named to the list of BioSpace Movers and Shakers in July 2020 after veteran health plan executive Dennis A. Matheis joined its Board of Directors Global digital diabetes management market is projected to register CAGR of 17.8% by 2026 DarioHealth’s platform lauded for centering on continual maximization of patient engagement DarioHealth (NASDAQ: DRIO), a global digital therapeutics company serving its users with dynamic mobile health solutions, is in the spotlight as a major global player in the digital diabetes management market. A recent report published by Data Bridge Market Research featured DarioHealth and its advancements in digital…

ThursdayJul 16, 2020 10:00 am

How Research Sites Can Be Reopened Safely

Many clinical researchers are still doing their work behind closed doors. Despite being in the middle of the pandemic, they have tried to keep their trials or tests going remotely and they would want to open again fully. It is not the researchers alone who are eager for the research sites to open. Other stakeholders, including interns, have found themselves in that dilemma. For instance, in the U.S., the three-phase plan for reopening the country indicates that researchers may return to work soon. As your research teams are preparing to return to their work stations, the safety of patients and…

WednesdayJul 15, 2020 3:00 pm

Trends Likely to Develop Following the Coronavirus Pandemic

When the coronavirus pandemic reached the U.S., the FDA reacted swiftly to come up with quick solutions. In a few weeks, emergency testing was already in place, and that was an opportunity to convert some of the machines to be used as ventilators. The pandemic has paved the way for some new changes and trends, and they are going to have a significant impact on the medical industry. Here are five medical trends we could see very soon: Approval Time is Going to be Faster As the FDA’s emergency testing initiative is likely to expire, a backlog in approving medical…

WednesdayJul 15, 2020 12:19 pm

Vivos Therapeutics, Inc. Looking At Significant Forecasted Growth of Sleep Apnea Devices Market

Sleep apnea devices market growth also driven by the current pandemic which has made it exponentially more difficult for patients to seek treatment for their condition Registered with the FDA as a Specification Developer, Vivos develops and markets the first non-surgical, non-invasive and cost-effective solution for the estimated billion of people globally who suffer from OSA Vivos believes its proprietary system is poised to provide the most significant breakthrough in OSA treatment since CPAP The global sleep apnea market is expanding rapidly, being expected to reach $13.24 billion by 2027, from $7.81 billion in 2019, exhibiting a CAGR of 6.8…